Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

Detalles Bibliográficos
Autores principales: Lin, Xixi, Jia, Yongliang, Dong, Xinwei, Shen, Jian, Jin, Yachao, Li, Yanyou, Wang, Fang, Anenberg, Eitan, Zhou, Jiancang, Zhu, Jianping, Chen, Xiaoping, Xie, Qiangmin, Xie, Yicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097790/
https://www.ncbi.nlm.nih.gov/pubmed/35571124
http://dx.doi.org/10.3389/fphar.2022.890886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097790/
https://www.ncbi.nlm.nih.gov/pubmed/35571124
http://dx.doi.org/10.3389/fphar.2022.890886

Ejemplares similares